Clinical Trial Update: Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy [Phase 4]

View source ↗

Summary

Phase 4 trial of single-shot intrathecal ziconotide for painful myelopathy or painful neuropathy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Myelopathy
• Painful Neuropathy

Drugs mentioned

• Ziconotide (ziconotide)

Snippet

Sponsor: Aaron Boster | Conditions: Painful Myelopathy, Painful Neuropathy | Phase 4 | Status: WITHDRAWN